Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2019 13:13 ET | Source: Prevent Cancer Foundation

Think you’re “Too Young for This Sh*t?” Think again.

Alexandria, Va., March 25, 2019 (GLOBE NEWSWIRE) -- It’s a common misconception that colorectal cancer affects only older people—but today, more adults under the recommended screening age are being...
March 19, 2019 10:00 ET | Source: Labaton Sucharow LLP

Labaton Sucharow Files Class Action against AbbVie And Other Drugmakers, Alleging Anti-Competitive Practices to Block Competition for Blockbuster Drug Humira in the United States

NEW YORK, March 19, 2019 (GLOBE NEWSWIRE) -- Labaton Sucharow LLP has filed a class action lawsuit against drugmaker AbbVie Inc. and a group of global rivals, alleging the company colluded to divide...
March 19, 2019 07:45 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Reports Financing to Initiate the First Phase 3 Clinical Trial in Celiac Disease, Fiscal Year 2018 Earnings and Key Corporate Highlights

Innovate closes an equity financing with gross proceeds of $9.7 million Continued launch activities for start of the first Phase 3 celiac disease trial, expected to start Q2 2019 Continued research...
March 18, 2019 19:30 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 19, 2019

RALEIGH, N.C., March 18, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and...
March 18, 2019 08:51 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical Trial

RALEIGH, N.C., March 18, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate” or the “Company”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel...
March 13, 2019 19:00 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 18, 2019

RALEIGH, N.C., March 13, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and...
March 07, 2019 16:30 ET | Source: Immutep Limited

Immutep Presents Positive IMP761 Preclinical Results at 14th Congress of European Crohn’s and Colitis Organisation

SYDNEY, Australia, March 07, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer...
March 06, 2019 09:00 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Announces Presentation at Cowen’s 39th Annual Health Care Conference in Boston

RALEIGH, N.C., March 06, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation...
March 01, 2019 17:33 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 14, 2019

RALEIGH, N.C., March 01, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and...
February 27, 2019 01:17 ET | Source: Esperite N.V.

Esperite N.V. (ESP) with The Cell Factory has confirmed a long-term effect of extracellular vesicle drug candidate CF-MEV-132 for the treatment of Bronchopulmonary Dysplasia.

CF-MEV-132 drug candidate belongs to the CF-MEV family of anti-inflammatory EV drugs produced by The Cell Factory Amsterdam, The Netherlands – 27 February 2019 The Cell Factory and the...